Analytical Tools for Characterization and Safety Testing of Gene Edited Allogeneic CAR-T Cell Therapies

Time: 10:15 am
day: Day Two

Details:

• Introduction to production and safety considerations associated with allogeneic CAR-T products

• Review assays and techniques to characterize efficiency of gene editing

• Examine analytical methods to assess product safety profiles specific to gene editing processes (flow cytometry, qPCR/ddPCR, ELISA, and NGS)

Speakers: